Arkolith/Insider Trading/AKTX/Form 4

Farag Kameel D.

Interim CFOAkari Therapeutics Plc (AKTX) · full profile →Form 4 · filed Nov 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 1, 2025Grant(A)27K$0.75$20K27K
Nov 1, 2025Grant(A)32K$0.75$24K32K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-020753) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML